Hangzhou AGS MedTech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005ZF0
CNY
58.78
-0.17 (-0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
628.43
504.36
367.24
302.21
170.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
628.43
504.36
367.24
302.21
170.19
Raw Material Cost
182.45
150.93
121.03
110.88
70.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
182.02
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.37
0.25
0.23
0.14
0.09
Selling and Distribution Expenses
102.73
96.26
65.59
50.84
35.03
Other Expenses
-12.40
4.03
3.04
2.34
1.79
Total Expenditure (Excl Depreciation)
343.61
287.79
217.27
185.28
123.14
Operating Profit (PBDIT) excl Other Income
284.8
216.6
150
116.89999999999999
47.1
Other Income
59.62
35.81
16.75
2.75
4.63
Operating Profit (PBDIT)
351.92
259.18
173.37
125.37
56.11
Interest
0.37
0.25
0.23
0.14
0.09
Exceptional Items
2.09
0.45
0.13
1.09
0.00
Gross Profit (PBDT)
445.98
353.43
246.22
191.33
100.08
Depreciation
10.05
7.71
7.70
6.36
4.98
Profit Before Tax
343.60
251.67
165.56
119.97
51.03
Tax
50.21
34.43
20.60
15.17
5.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
293.39
217.24
144.96
104.80
45.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
293.39
217.24
144.96
104.80
45.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
293.39
217.24
144.96
104.80
45.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
2,397.11
2,208.24
381.54
271.45
216.69
Earnings per share (EPS)
3.64
2.68
1.79
1.29
0.56
Diluted Earnings per share
3.64
2.68
1.79
1.29
0.56
Operating Profit Margin (Excl OI)
44.92%
42.76%
40.55%
38.47%
27.32%
Gross Profit Margin
56.27%
51.43%
47.18%
41.8%
32.91%
PAT Margin
46.69%
43.07%
39.47%
34.68%
26.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 24.58% vs 37.36% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 35.08% vs 49.79% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 30.84% vs 42.66% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 33.33% vs 50.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Hangzhou AGS MedTech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
628.43
0
628.43
Other Operating Income
0.00
0.00
0.00
Total Operating income
628.43
0
628.43
Raw Material Cost
182.45
0
182.45
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
182.02
0
182.02
Power Cost
0
0
0.00
Manufacturing Expenses
0.37
0
0.37
Selling and Distribution Expenses
102.73
0
102.73
Other Expenses
-12.40
0.00
-12.40
Total Expenditure (Excl Depreciation)
343.61
0
343.61
Operating Profit (PBDIT) excl Other Income
284.82
0.00
284.82
Other Income
59.62
0
59.62
Operating Profit (PBDIT)
351.92
0
351.92
Interest
0.37
0
0.37
Exceptional Items
2.09
0
2.09
Gross Profit (PBDT)
445.98
0
445.98
Depreciation
10.05
0
10.05
Profit Before Tax
343.60
0
343.60
Tax
50.21
0
50.21
Provisions and contingencies
0
0
0.00
Profit After Tax
293.39
0
293.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
293.39
0
293.39
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
293.39
0
293.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,397.11
0
2,397.11
Earnings per share (EPS)
3.64
0
3.64
Diluted Earnings per share
3.64
0
3.64
Operating Profit Margin (Excl OI)
44.92%
0%
0.00
44.92%
Gross Profit Margin
56.27%
0%
0.00
56.27%
PAT Margin
46.69%
0%
0.00
46.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 62.84 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 24.58% vs 37.36% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 29.34 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.08% vs 49.79% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 30.84% vs 42.66% in Dec 2023

Annual - Interest
Interest 0.04 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 33.33% vs 50.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 44.92%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023